In this study, SETD4-positive qLCSCs were examined in NSCLC patients who received platinum-based chemotherapy, and high SETD4 expression was found to be correlated with poor chemotherapy efficacy and prognosis. This evidence concerns the gene SETD4 and non-small cell lung carcinoma.